• Ovacome Home Page
• Holding Onto Hope
• Help BEAT ovarian cancer with Ovacome
• Contact your MP to take action to tackle ovarian cancer
• About Ovarian Cancer
  • Symptoms of ovarian cancer
  • Types of ovarian cancer
  • Staging and grades
  • Treatment
  • Medical terminology
  • Risks
  • Screening
  • Familial ovarian cancer
  • Clinical trials
• My Ovarian Cancer
• Resources
• My Ovacome
• Support Us
• About Us
• Media
• News
• Search

Clinical trials

This is a list of current clinical trials that may be of interest to women with ovarian cancer.

To learn more about the trials, click on the link to be taken to the trial page. If you would like to discuss any aspect of clinical trials in general, please call us on 0845 371 0554 to speak to a nurse.

DNA Methylation
A trial to see if cell changes can help tell doctors who will respond to chemotherapy for ovarian cancer.

ICON6
A trial to see if whether adding a new drug Cediranib to standard treatment is beneficial in patients where the disease has returned more than 6 months after the intial treatment.

HOT11
This is a trial to see if giving oxygen therapy in a special way (hyperbaric) can help people who have suffered from long term side effects from radiotherapy damage to the pelvis.

AG-014699
A trial looking at a new drug for breast and ovarian cancer, in people with BRCA gene faults.

Gem-TIP
This trial is to find out more about giving the chemotherapy drugs gemcitabine (Gemzar), paclitaxel (Taxol), ifosfamide and cisplatin for advanced germ cell cancer that has come back (relapsed).

mEOC
This trial is comparing 2 different chemotherapy combinations with or without bevacizumab (Avastin) for a rare type of ovarian cancer called mucinous epithelial ovarian cancer.

SaPPrOC
A study looking at Paclitaxel with or without Saracatinib for ovarian, fallopian tube or primary peritoneal cancer that has come back.

ICON8
A trial looking at weekly chemotherapy for ovarian cancer

NKTR-102
A trial of NKTR-102 for advanced ovarian cancer that is resistant to platinum drugs

Biomarkers
A study looking at using biomarkers to help doctors choose suitable treatment for women with ovarian or womb cancer

Mercaptopurine and Methotrexate
This trial is looking at 2 chemotherapy drugs called mercaptopurine and methotrexate. It is for people with an inherited fault in the BRCA1 or BRCA2 gene who have locally advanced or secondary breast cancer, or advanced ovarian cancer that has come back after other treatment

Borderline ovarian tumours
This study is looking at tissue samples and clinical information to learn more about borderline ovarian tumours and how to improve treatment.

PETROC
A trial comparing different combinations of chemotherapy after surgery for women with ovarian cancer who have already had chemotherapy before surgery.